如何在HIV感染者中筛查结核并开展结核预防性治疗
本文为叙述性综述,整合国际HIV/TB指南与近期关键研究,阐述HIV感染者结核感染筛查策略、活动性结核排除、TPT方案选择、与ART的药物相互作用及随访。强调所有HIV感染者在确诊时均应评估结核与结核感染,TPT需个体化并与ART整合。
要点
- 所有HIV感染者在确诊HIV时应评估结核与结核感染。
- 无症状者筛查TBI用TST或IGRA,晚期免疫抑制者敏感性降低。
- TBI检测阳性需通过临床评估、胸部影像及必要微生物学检查排除活动性结核。
核心结论
- HIV感染者TBI管理需系统筛查、及时启动有效且个体化的TPT、与ART谨慎整合及结构化随访。
研究设计与样本
- 叙述性综述,整合当前国际HIV/TB指南与近期关键研究,并附代表性临床案例。
主要发现
- HIV感染者较一般人群从TBI进展为活动性结核的风险显著更高,尤其在晚期免疫抑制、延迟ART、社会脆弱性及照护连续性障碍时。
- 无症状个体TBI筛查依赖结核菌素皮肤试验或干扰素γ释放试验,但两者在晚期免疫缺陷时敏感性降低。
- TBI检测阳性需通过临床评估、胸部影像及必要时的微生物学检查排除活动性结核。
关键数值与推荐
- 所有HIV感染者在HIV诊断时应评估结核与结核感染。
- 可用TPT方案包括以异烟肼为基础和以利福霉素为基础的方案,选择应依据耐受性、可行性和预期依从性个体化。
- 利福霉素与ART相互作用需特别考虑,常需调整抗逆转录病毒方案并密切病毒学监测。
- 随访应包括依从性、毒性、肝功能评估及维持HIV照护 linkage。
临床怎么用
- 对所有新诊断HIV感染者系统评估结核与TBI,无症状者行TST或IGRA筛查。
- TBI检测阳性者先排除活动性结核,再启动个体化TPT。
- 使用利福霉素类TPT时评估与ART的相互作用,必要时调整ART并密切监测病毒学。
- TPT期间随访依从性、毒性、肝功能并维持HIV照护 linkage。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tuberculosis infection (TBI) remains a major cause of preventable morbidity and mortality in people with HIV (PWH). Compared with the general population, PWH have a substantially higher risk of progression from TBI to active tuberculosis (TB), especially in the setting of advanced immunosuppression, delayed antiretroviral therapy (ART), social vulnerability, and barriers to continuity of care. Early diagnosis and timely TB preventive treatment (TPT) are therefore essential components of comprehensive HIV care. OBJECTIVES: To summarize the current approach to the diagnosis and treatment of TBI in PWH, with particular attention to screening strategies, exclusion of active TB, selection of TPT regimens, drug-drug interactions with ART, and follow-up. SOURCES: This narrative review integrates current international HIV/TB guidelines and recent key studies, together with a representative clinical vignette illustrating common diagnostic and therapeutic challenges. CONTENT: All PWH should be assessed for TB and TBI at HIV diagnosis. In asymptomatic individuals, screening for TBI relies on tuberculin skin test or interferon-gamma release assay, although both have reduced sensitivity in advanced immunodeficiency. A positive test requires exclusion of active TB through clinical assessment, chest imaging, and microbiological investigations when indicated. Available TPT options include isoniazid- and rifamycin-based regimens, whose choice should be individualized according to tolerability, feasibility, and expected adherence. Special consideration is required for interactions between rifamycin and ART, often necessitating antiretroviral regimen adjustment and close virological monitoring. Follow-up should include assessment of adherence, toxicity, liver function, and maintenance of HIV care linkage. IMPLICATIONS: Optimal management of TBI in PWH requires systematic screening, prompt initiation of effective and individualized TPT, careful integration with ART, and structured follow-up. Strengthening linkage to care and improving access to shorter, safer preventive regimens are critical to reducing TB-related morbidity and mortality in this high-risk population.
引用
- Raccagni AR, Antonello RM, Pieruzzi M, et al. How do I screen for tuberculosis and provide tuberculosis preventive treatment in people with HIV? Clin Microbiol Infect. 2026. PMID: 42532268. doi:10.1016/j.cmi.2026.07.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。